Clinical trial · Observational
Survey Assessment of Patient and Provider Impressions of Telemedicine in Radiation Oncology
NCT05496972CI-TRIAL-00112241active not recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To understand more about the opinions of patients and health providers on the use of telemedicine in radiation oncology.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Hematopoietic and Lymphoid Cell Neoplasm | Hematopoietic and Lymphoid Cell Neoplasm | ONTOLOGY_EXACT | 0.98 |
| Malignant Solid Neoplasm | Malignant Solid Neoplasm | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Survey Administration | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Telemedicine Visits
- description
- Participants are asked to fill out a survey about their experience.
- interventionNames
- Behavioral: Survey Administration
Primary outcomes (2)
- measure
- Patient satisfaction survey with telemedicine in radiation oncology (RO)
- timeFrame
- through study completion and average of one year.
- description
- Sensitivity analyses will be performed with those rating 9 or higher or less than 9, and for those who "agree" or "strongly agree" with whether they are satisfied with telemedicine compared to those who give other answers.
- measure
- Provider satisfaction survey with telemedicine in radiation oncology (RO)
- timeFrame
- through study completion and average of one year.
- description
- Sensitivity analyses will be performed with those rating 9 or higher or less than 9, and for those who "agree" or "strongly agree" with whether they are satisfied with telemedicine compared to those who give other answers.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients will be eligible if they are aged 18 or older and have undergone at least 1 telemedicine encounter (video visit) with the radiation oncology department at MD Anderson or its affiliates within 2 months from the initiation of the study (and prospectively as the study enrolls). This would include weekly see visits, follow-up visits, or consultations * English speaking * Access to email and internet to complete the survey * Attending physicians in the radiation oncology department who have utilized telemedicine will be contacted to fill out surveys reflecting their experience Exclusion Criteria: • Protected populations such as adults unable to consent, pregnant women, prisoners, and individuals who are not yet adults will be excluded
References
Publications (0)
Data not yet available
No reference posted for this study.